{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:08:51Z","timestamp":1792080531742,"version":"4.4.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91856126 81870606 21778042"],"award-info":[{"award-number":["91856126 81870606 21778042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ21H030002"],"award-info":[{"award-number":["LQ21H030002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo","doi-asserted-by":"publisher","award":["2019A610209"],"award-info":[{"award-number":["2019A610209"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Nonalcoholic steatohepatitis (NASH) has become one of the serious causes of chronic liver diseases, characterized by hepatic steatosis, hepatocellular injury, inflammation and fibrosis, and lack of efficient therapeutic agents. Palmitoylethanolamide (PEA) is an endogenous bioactive lipid with various pharmacological activities, including anti-inflammatory, analgesic, and neuroprotective effects. However, the effect of PEA on nonalcoholic steatohepatitis is still unknown. Our study aims to explore the potential protective role of PEA on NASH and to reveal the underlying mechanism. In this study, the C57BL\/6 mice were used to establish the NASH model through methionine- and choline-deficient (MCD) diet feeding. Here, we found that PEA treatment significantly improved liver function, alleviated hepatic pathological changes, and attenuated the lipid accumulation and hepatic fibrosis in NASH mice induced by MCD diet feeding. Mechanistically, the anti-steatosis effect of PEA may be due to the suppressed expression of ACC1 and CD36, elevated expression of PPAR-<jats:italic>\u03b1<\/jats:italic>, and the phosphorylation levels of AMPK. In addition, hepatic oxidative stress was greatly inhibited in MCD-fed mice treated with PEA via enhancing the expression and activities of antioxidant enzymes, including GSH-px and SOD. Moreover, PEA exerted a clear anti-inflammatory effect though ameliorating the expression of inflammatory mediators and suppressing the NLRP3 inflammasome pathway activation. Furthermore, the impaired autophagy in MCD-induced mice was reactivated with PEA treatment. Taken together, our research suggested that PEA protects against NASH through the inhibition of inflammation and restoration of autophagy. Thus, PEA may represent an efficient therapeutic agent to treat NASH.<\/jats:p>","DOI":"10.3389\/fphar.2021.744483","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T17:42:42Z","timestamp":1634146962000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Micronized Palmitoylethanolamide Ameliorates Methionine- and Choline-Deficient Diet\u2013Induced Nonalcoholic Steatohepatitis via Inhibiting Inflammation and Restoring Autophagy"],"prefix":"10.3389","volume":"12","author":[{"given":"Jiaji","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanglu","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jhep.2019.01.026","article-title":"Autophagy in Liver Diseases: Time for Translation?","volume":"70","author":"Allaire","year":"2019","journal-title":"J. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1586\/egh.11.4","article-title":"Autophagy in Nonalcoholic Steatohepatitis","volume":"5","author":"Amir","year":"2011","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1096\/fj.201901510RR","article-title":"Palmitoylethanolamide Counteracts Hepatic Metabolic Inflexibility Modulating Mitochondrial Function and Efficiency in Diet-Induced Obese Mice","volume":"34","author":"Annunziata","year":"2020","journal-title":"FASEB J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"101143","DOI":"10.1016\/j.molmet.2020.101143","article-title":"Metabolic Drivers of Non-alcoholic Fatty Liver Disease","volume":"50","author":"Bence","year":"2021","journal-title":"Mol. Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cmet.2019.11.013","article-title":"Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis","volume":"31","author":"Cai","year":"2020","journal-title":"Cell Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"42530","DOI":"10.18632\/oncotarget.6466","article-title":"Oleoylethanolamide, an Endogenous PPAR-\u03b1 Ligand, Attenuates Liver Fibrosis Targeting Hepatic Stellate Cells","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s10337-014-2708-7","article-title":"Rapid and Sensitive LC-MS\/MS Analysis of Fatty Acids in Clinical Samples","volume":"77","author":"Chen","year":"2014","journal-title":"Chromatographia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejphar.2015.11.012","article-title":"Protective Role of Autophagy in Methionine-Choline Deficient Diet-Induced Advanced Nonalcoholic Steatohepatitis in Mice","volume":"770","author":"Chen","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of Oxidative Stress in the Pathogenesis of Nonalcoholic Fatty Liver Disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"595371","DOI":"10.3389\/fmed.2021.595371","article-title":"Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review","volume":"8","author":"Delli Bovi","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic Fatty Liver Disease: a Practical Approach to Diagnosis and Staging","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/hep.30097","article-title":"Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents","volume":"68","author":"Goedeke","year":"2018","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1179","DOI":"10.1038\/cddis.2014.162","article-title":"Impaired Autophagic Flux Is Associated with Increased Endoplasmic Reticulum Stress during the Development of NAFLD","volume":"5","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2014","journal-title":"Cell Death Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"605065","DOI":"10.3389\/fphar.2020.605065","article-title":"Oleoylethanolamide Protects against Acute Liver Injury by Regulating Nrf-2\/HO-1 and NLRP3 Pathways in Mice","volume":"11","author":"Hu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32066","article-title":"Salidroside Activates the AMP\u2010activated Protein Kinase Pathway to Suppress Non\u2010alcoholic Steatohepatitis","author":"Hu","year":"2021","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"154797","DOI":"10.1016\/j.metabol.2021.154797","article-title":"A New Mechanism of Obeticholic Acid on NASH Treatment by Inhibiting NLRP3 Inflammasome Activation in Macrophage","volume":"120","author":"Huang","year":"2021","journal-title":"Metabolism"},{"key":"B17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2337\/db09-0016","article-title":"Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance","volume":"59","author":"Huang","year":"2010","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"11364","DOI":"10.1096\/fj.201900538R","article-title":"The Neuroprotective Effects of Micronized PEA (PEA-M) Formulation on Diabetic Peripheral Neuropathy in Mice","volume":"33","author":"Impellizzeri","year":"2019","journal-title":"FASEB J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/jhep.2003.50307","article-title":"Central Role of PPARalpha-dependent Hepatic Lipid Turnover in Dietary Steatohepatitis in Mice","volume":"38","author":"Ip","year":"2003","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular Mechanisms of Hepatic Lipid Accumulation in Non-alcoholic Fatty Liver Disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/cr.2013.161","article-title":"Autophagy and Human Diseases","volume":"24","author":"Jiang","year":"2014","journal-title":"Cell Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/md18040222","article-title":"Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway","volume":"18","author":"Jin","year":"","journal-title":"Mar. Drugs"},{"key":"B23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41419-020-2293-7","article-title":"Antagonizing circRNA_002581-miR-122-CPEB1 axis Alleviates NASH through Restoring PTEN-AMPK-mTOR Pathway Regulated Autophagy","volume":"11","author":"Jin","year":"","journal-title":"Cel Death Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The Role of Macrophages in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and Cellular Mechanisms of Liver Fibrosis and its Regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31749","article-title":"Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway","volume":"74","author":"Lan","year":"2021","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jphs.2014.12.001","article-title":"Effect of Oleoylethanolamide on Diet-Induced Nonalcoholic Fatty Liver in Rats","volume":"127","author":"Li","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"114398","DOI":"10.1016\/j.bcp.2020.114398","article-title":"Palmitoylethanolamide (PEA) Reduces Postoperative Adhesions after Experimental Strabismus Surgery in Rabbits by Suppressing Canonical and Non-canonical TGF\u03b2 Signaling through PPAR\u03b1","volume":"184","author":"Li","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-Alpha Mediates the Anti-inflammatory Actions of Palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and Disease Consequences of Nonalcoholic Fatty Liver Disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0127991","DOI":"10.1371\/journal.pone.0127991","article-title":"Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease","volume":"10","author":"Machado","year":"2015","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1053\/j.gastro.2015.09.042","article-title":"Regulation of Liver Metabolism by Autophagy","volume":"150","author":"Madrigal-Matute","year":"2016","journal-title":"Gastroenterology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fphar.2019.00405","article-title":"Matrine Protects against MCD-Induced Development of NASH via Upregulating HSP72 and Downregulating mTOR in a Manner Distinctive from Metformin","volume":"10","author":"Mahzari","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPAR\u03b1 Is Crucial for Whole-Body Fatty Acid Homeostasis and Is Protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 Inflammasome Blockade Reduces Liver Inflammation and Fibrosis in Experimental NASH in Mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular Mechanism of PPAR\u03b1 Action and its Impact on Lipid Metabolism, Inflammation and Fibrosis in Non-alcoholic Fatty Liver Disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/bph.13580","article-title":"The Pharmacology of Palmitoylethanolamide and First Data on the Therapeutic Efficacy of Some of its New Formulations","volume":"174","author":"Petrosino","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/bph.13084","article-title":"The Anti-inflammatory Mediator Palmitoylethanolamide Enhances the Levels of 2-Arachidonoyl-Glycerol and Potentiates its Actions at TRPV1 Cation Channels","volume":"173","author":"Petrosino","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"7475","DOI":"10.1021\/acs.jmedchem.0c00191","article-title":"N-acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition","volume":"63","author":"Piomelli","year":"2020","journal-title":"J. Med. Chem."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217942","article-title":"The Basal Pharmacology of Palmitoylethanolamide","volume":"21","author":"Rankin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jcmgh.2020.06.001","article-title":"Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems","volume":"10","author":"Ross","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and Resolution of Inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s12035-015-9253-8","article-title":"N-palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution","volume":"52","author":"Skaper","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"19034","DOI":"10.1074\/jbc.M115.640292","article-title":"Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance","volume":"290","author":"Steneberg","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 Inflammasome: Molecular Activation and Regulation to Therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41419-019-2214-9","article-title":"Targeting Alkaline Ceramidase 3 Alleviates the Severity of Nonalcoholic Steatohepatitis by Reducing Oxidative Stress","volume":"11","author":"Wang","year":"2020","journal-title":"Cel Death Dis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00782-2017","article-title":"Targeting Fatty Acid Amide Hydrolase as a Therapeutic Strategy for Antitussive Therapy","volume":"50","author":"Wortley","year":"2017","journal-title":"Eur. Respir. J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"577319","DOI":"10.3389\/fphar.2020.577319","article-title":"Natural Potent NAAA Inhibitor Atractylodin Counteracts LPS-Induced Microglial Activation","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"13565","DOI":"10.1038\/srep13565","article-title":"Potential Analgesic Effects of a Novel N-Acylethanolamine Acid Amidase Inhibitor F96 through PPAR-\u03b1","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9070578","article-title":"Serum Malondialdehyde Is Associated with Non-alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women","volume":"9","author":"Zelber-Sagi","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jhep.2019.03.014","article-title":"Macrophage P38\u03b1 Promotes Nutritional Steatohepatitis through M1 Polarization","volume":"71","author":"Zhang","year":"2019","journal-title":"J. Hepatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2002273","DOI":"10.1002\/advs.202002273","article-title":"The Nuclear Orphan Receptor NR2F6 Promotes Hepatic Steatosis through Upregulation of Fatty Acid Transporter CD36","volume":"7","author":"Zhou","year":"2020","journal-title":"Adv. Sci. (Weinh)"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.744483\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T17:42:45Z","timestamp":1634146965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.744483\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":52,"alternative-id":["10.3389\/fphar.2021.744483"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.744483","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]},"article-number":"744483"}}